[1] 向阳, 赵峻.妊娠滋养细胞疾病诊治进展[J]. 中国实用妇科与产科杂志, 2017, 33(1):14-18. [2] Braga A, Maesta L, Short D, et al. Hormonal contraceptive ust before hcg remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole:a historical database review[J]. BJOG, 2016,123(8):1330-1335. [3] Lu B, Zhang X, Liang Y. Clinicopathologic analysis of postchemotherapy gestational trophoblastic neoplasia:an entity overlapping with epithelioid trophoblastic tumor[J]. Int J Gynecol Pathol,2016,35(6):516-524. [4] Brooks SA, Martin E, Smeester L, et al. miRNAs as common regulators of the transforming growth factor (TGF)-β pathway in the preeclamptic placenta and cadmium-treated trophoblasts:Links between the environment, the epigenome and preeclampsia[J]. Food Chem Toxicol, 2016, 98(Pt A):50-57. [5] Bolat F, Haberal N, Tunali N, et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1a), and transforming growth factors β1(TGFβ1) and β3(TGFβ3) in gestational trophoblastic disease[J]. Pathol Res Prac, 2010, 206(1):19-23. [6] Singh MK, Bhattacharya D, Chaudhuri S, et al. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions[J]. Tumour Biol, 2014, 35(3):2231-2246. [7] 刘绍晨, 许倩, 岳志领.TGF-β1对人绒癌JEG-3细胞株TβRⅠ、TβRⅡ、Smad4 mRNA表达的影响及意义[J]. 中国妇幼保健, 2015, 30(5):758-763. [8] Fu G, Ye G, Nadeem L, et al. MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion[J]. Hypertension, 2013, 61(4):864-872. [9] Singh MK, Bhattacharya D, Chaudhuri S, et al. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions[J]. Tumour Biol, 2014, 35(3):2231-2246. [10] Wu Y, Fu Y, Zheng L, et al. Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axis[J]. Cancer Lett, 2014, 342(1):82-91. [11] Wu XD, Chen LL,Shen T, et al. Curative effects and influenced factors of primary chemotherapy with single-agent methotrexate on low-risk gestational trophoblastic neoplasia[J].Zhonghua Yi Xue Za Zhi, 2017, 97(23):1769-1772. [12] Schneider K, Weyerbrock A, Doostkam S, et al. Lack of evidence for PLGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas[J]. J Neuro Oncol, 2015, 121(2):269-278. [13] Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta[J].Biol Reprod,1997,56(2):489-494. [14] Xiang L,Varshney R,Rashdan NA, et al. Placental growth factor and vascular endothelial growth factor-A have differential, cell-type specific patterns of expression in vascular cells[J]. Microcirculation,2014, 21(5):368-379. [15] Tsiakkas A, Duvdevani N, Wright A, et al. Serum placental growth factor in the three trimesters of pregnancy:effects of maternal characteristics and medical history[J]. Ultrasound Obstet Gynecol, 2015, 45(5):591-598. [16] Song N, Liu H, Ma X, et al. Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7[J]. Cell Physiol Biochem, 2015, 37(3):1104-1112. [17] 李润花, 郑兆祥, 武明霞, 等. 胎盘生长因子及瘦素在早孕绒毛及妊娠滋养细胞疾病中的表达及意义[J]. 中华妇幼临床医学杂志:电子版, 2012, 8(4):485-488. [18] Oranratanaphan S, Wongwathanavikrom R, Lertkhachonsuk R. Correlation levels of serum placental growth factor and human chorionic gonadotropin in gestational trophoblastic disease patients[J]. J Reprod Med, 2011, 56(7/8):333-338. [19] De Falco S. The discovery of placenta growth factor and its biological activity[J]. Exp Mol Med, 2012, 44(1):1-9. [20] Singh M, Kindelberger D, Nagymanyoki Z, et al. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta[J]. J Reprod Med, 2012, 57(5/6):197-203. [21] Incio J, Tam J, Rahbari NN, et al. PLGF/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity[J]. Clin Cancer Res, 2016, 22(12):2993-3004. [22] Shamshiri Milani H, Abdollahi M, Torbati S, et al. Risk factors for hydatidiform mole:Is husband's job a major risk factor[J].Asian Pac J Cancer Prev,2017, 18(10):2657-2662. [23] Giorgione V, Bergamini A, Cioffi R, et al.Role of surgery in the management of hydatidiform mole in elderly patients:a single-center clinical experience[J]. Int J Gynecol Cancer,2017,27(3):550-553. |